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Abstract
The success of cancer treatments have resulted in a rapid growth of survivors, providing
the impetus for the oncology community to examine models of care supporting smooth
transition from active treatment to survivorship care. While initially a recommendation of
the Institute of Medicine, treatment summaries and survivorship care plans are now an
accreditation requirement for many organizations. This article describes the
implementation of an evidence based practice project designed to meet these standards
while improving the knowledge and satisfaction of a population of breast cancer patients
at a community-based oncology practice.
Background
Today, an estimated 14.5 million people are survivors of cancer, and the number
is steadily rising due to dramatic and rapid advances in the screening, diagnosis, and
treatment of cancer.1,2 Breast cancer survivors are a prominent subset, accounting for 3.1
million survivors.3 Projections are that 68% of adults with cancer are expected to be alive
in 5 years, a remarkable upward trend from 1977 when the 5-year survival rate was a
mere 49%.1 Regarding breast cancer, a woman diagnosed today, has an 89% chance of
being alive in 5-years, 83% in 10 years, and 78% at 15 years.2
These expanding categories of patients, those presumed cured, and those living
with cancer as a chronic disease, present a new dilemma in the paradigm of cancer care.
Oncology providers are taxed with evaluating the evidence of a rapid expansion of fasttracked chemotherapeutics, biologic agents, and immunotherapies and how to best
sequence therapy. The demand to keep pace in the area of acute oncology has
overshadowed the growing concerns on both ends of the spectrum of oncology care:
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those who survive their disease and those who will succumb. The evaluation and
implementation of care models to transfer these responsibilities to other qualified
providers is a vexing challenge.

In the 2006 Institute of Medicine (IOM) Report, From Cancer Patient to Cancer
Survivors: Lost in Transition, survivorship care was described as falling short of the ideal
being plagued with poor communication, fragmentation, and lack of coordination of
services. Inappropriate use of services, lack of attention to late- and long-term effects,
and the absence of preventive care were also cited.4 A major limitation of their
survivorship care reported by patients was insufficient communication between their
oncologist and primary care provider (PCP), leading to feelings of anxiety and
abandonment.5,6 A significant proportion of PCPs, 84%, report being uncertain of the
frequency and type of surveillance tests they should be ordering.7 Critical to monitoring
survivors of cancer, is understanding the long-term side effects of the drugs and treatment
modalities employed.8 In the 2009 Survey of Physician Attitudes Regarding the Care of
Cancer Survivors, of the 1072 PCPs who responded, only 6% were able to identify the
four most common late adverse effects of the four most commonly used
chemotherapeutics.9

Of the 10 recommendations for improving the care of survivors cited by the IOM,
only recommendation two: “Patients completing primary treatment should be provided
with a comprehensive care summary and follow–up plan…4” was concrete, and clearly
directed to providers of oncology care.
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Current cancer treatment modalities save many more lives then in the past but
have considerable consequences and are far from benign.10,11 The cancer experience does
not culminate upon the completion of treatment and most survivors are left with physical
and psychosocial lasting and latent effects.10,12 Survivorship is a distinct phase in the
trajectory of the cancer experience.4 Studies of survivors report more then 25 problems
and needs following treatment including fatigue, sleep deprivation, pain, depression,
anxiety, and fear of recurrence.4,6,10,13 Survivors of breast cancer also express concerns of
weight gain, skin changes, pain, lymphedema, cognitive impairment, and for those with
hereditary breast cancer syndromes, risk to family members.4,10,13,14 Side effects of
estrogen deprivation: hot flashes, vaginal dryness, premature menopause, infertility, and
risk of osteoporosis also affect quality of life.4,13 For breast cancer survivors, high levels
of stress and feeling uninformed on the persistent side effects of cancer treatment give
rise to feelings of isolation, anxiety, and depression.6,15

Cancer survivors have more co-morbidities and chronic health problems then the
general population, and are at risk for receiving inadequate health care.6,12 At the
conclusion of active treatment, survivors report wanting more information about their
diagnosis, treatment, long-term side effects, risk of recurrence, and health maintenance.6
As the immediate crisis of diagnosis and treatments wanes, insurance issues, occupational
concerns, medical bills, and relational issues become paramount as the survivors begin
the process of finding their “new normal”.6,16

Treatment summaries and survivorship care plans (TS/SCP) were designed to
synopsize the modalities used in treating a patient’s cancer, and as a guideline for follow-
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up care.4 The provision of a TS/SCPs and survivorship care is now a core measure of the
American College of Surgeons Commission on Cancer (CoC), American Society of
Clinical Oncology Quality Oncology Practice Initiative (ASCO QOPI®), and the
National Accreditation Program for Breast Centers (NAPBC).17–19 Presently, only 43% of
the National Cancer Institute (NCI) designated cancer centers provide TS/SCPs for breast
and/or colorectal cancer survivors.7 A national survey of 1130 medical oncologists
reported always/almost always discussing some aspect of survivorship care 64% of the
time; however, less then 10% report consistently providing a written TS/SCP.20
Practice Innovation
Aim
The purpose of this evidence-based practice project (EBP) was to incorporate a
TS/SCP for women completing adjuvant treatment for breast cancer that would enhance
their knowledge and satisfaction with care. The TS/SCP and survivorship visit were
designed to provide clarity to the breast cancer survivor on the frequency and purpose of
the follow-up visits, and to educate on the possible long- and late effects of treatment,
assess risk factors, and teach healthy behaviors to minimize recurrence and secondary
cancers. An additional goal was to disseminate this information to the providers involved
in the patient’s ongoing care.
Local Problem and Setting
California Cancer Associates for Research and Excellence (cCARE) is a
community-based, multi-location, large oncology hematology practice located in
Southern and Central California. This practice innovation was incorporated in a single
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office setting with two full time oncologists, along with one full time, and one part time
Nurse Practitioner (NP).
At the start of treatment, significant time and resources are allocated in preparing
the patient for chemotherapy through a formal, standardized chemotherapy-teaching
protocol. At the completion of adjuvant chemotherapy, no formal visits or written
materials addressing survivorship, or TS/SCP were provided. The oncologists and NPs
jointly shared post treatment follow-up visits aligned with ASCO’s evidence based
guidelines. No written protocol outlining the oncology follow-up care existed to formally
communicate with the patient or their providers.
Benchmark and Evaluation
Participants’ confidence in their knowledge of survivorship care was measured
pre- and post visit using the Confidence In Survivorship Information (CSI) tool. It was
anticipated improvement would occur for at least 80% of the women. The CSI tool is a
validated, 13-item, 3-point Likert-type scale developed for this population. Three items
measure survivors’ confidence in knowledge of diagnosis and treatment details; the
reliability was established with a Cronbach’s alpha= 0.77. The remaining 10 items,
Cronbach’s alpha=0.95, measure confidence in prevention, late- and long-term effects of
treatment and the cancer, prevention of future disease, familiar risk for cancer, and access
to resources. Respondents rate each item as “not at all confident”, “somewhat confident,”
or “very confident”.21
The benchmark for satisfaction, set at 80%, was measured using the Patient
Satisfaction with Cancer-related Care (PSCC) tool. The PSCC is a validated tool of 18
item with a 5-point Likert scale where “5=Strongly Agree and 1=Strongly Disagree”. It
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demonstrates high construct validity, internal consistency, and reliability with diverse
socioeconomic and cultural populations.22
The provider satisfaction tool was investigator developed, designed to be
answered in less then three minutes, and consisted of three question using a 5-point
Likert scale. The goal was for 80% of the providers to agree/strongly agree the TS/SCP
was easy to understand, useful in promoting effective patient care, and provided pertinent
information.
Implementation
After obtaining IRB approval, the project was guided using the John Hopkins
Nursing Evidence-Based Practice Model. The model has a practice process with three
areas of focus: practice question, evidence, and translation (Figure 1). The practice
question was initiated by the NPs at the site and supported by the oncologist and staff
who actively participated in the design and execution of the program. A comprehensive
review of the literature provided the evidence base and examples of numerous written
and computerized templates in which TS/SCPs had been implemented in various
oncology settings, both academic and community-based.
Translation of the evidence into a working model began at the start of care. The
Journey Forward Care Plan Builder© was downloaded onto the medical assistant (MA)
and NP computers. A standard breast cancer survivorship template reflecting resources
and practice patterns of the office was loaded onto a shared drive. At the time of the
chemotherapy-teaching visit, the MA solicited the information to complete the
demographic and care team portion of the TS/SCP. Using the pathology report,
chemotherapy orders, and oncology consultation, the NP completed the background
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information and treatment plan. An estimation of the date of completion of treatment was
made and noted in a file. Each month the NP reviewed the progress of patients and a 50minute survivorship visit was scheduled for those completing treatment. Prior to the visit,
the NP completed the remaining sections of the TS/SCP.
On the day of the survivorship visit, participants received an explanation of the
EBP project and were invited to participate in the pre/post evaluation process.
Participants were given the opportunity to opt out of completing any or all parts of the
evaluation. Participants electing to opt out still received the survivorship visit and
personalized TS/SCP.
During the visit, the NP reviewed the TS/SCP and the NCI booklet, Facing
Forward: Life After Cancer Treatment. Input was solicited on lingering effects of
treatment, questions answered, and referrals generated. Modifications were made based
on participant’s input, and a revised hard copy was printed. The TS/SCP was scanned
into the EMR and a personalized survivorship visit note was generated using a standard
template. The PCP and care team were mailed a brief letter of explanation, the TS/SCP,
provider survey, a self-addressed stamped envelope, and a $5.00 coffee gift card. Each
provider was surveyed only once.
Results
During the evaluation period, 21 women participated in the practice innovation.
Of the 26 providers who were mailed a TS/SCP, 19 (73%) returned the survey. Mean
confidence in knowledge of cancer diagnosis/treatment details improved from 1.57 to 2.0.
Similarly, mean confidence scores improved from .82 to 1.85 (t=8.66) in knowledge of
prevention, late/long-term effects, resources, and familiar risk for cancer (Figure 2).
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Improvement occurred for 100% of the participants. Satisfaction was rated at 4 or better
for 95% of the women and 84% of providers’ agreed/strongly agreed with the elements of
the survey (Figure 3).
Economics
An analysis of cost per visit was estimated. Average reimbursement by payer mix
for a level five follow-up visit was obtained. Estimates of NP and the MA resources
based on hourly rate to complete all parts of the project were subtracted from the average
reimbursement. An additional $5.00 in cost was added to cover the printing of the NCI
booklet. It was estimated that each visit generated approximately $25-$30 revenue.
Discussion
Arguably, there are far worse diseases then cancer, but few in which people
associate so dramatically with suffering, pain, and premature death. While feeling
relatively well, the newly diagnosed cancer patient is thrust into a treatment plan that is
difficult, lengthy, and potentially debilitating. Throughout the diagnosis and treatment,
patients have numerous contacts with multiple healthcare providers. At the completion of
treatment, this frequent contact suddenly, and abruptly, ceases. As previously stated, the
literature on the residual physical, emotional, and psychosocial effects of cancer and its
treatment is extensive. Therefore, it is paramount for the medical community to recognize
the inherit anxiety emerging at the completion of primary cancer treatment and to
embrace survivorship as a significant transition point.4
At the conclusion of adjuvant cancer treatment, the questions and concerns of the
cancer patient are different. As early apprehensions around treatment side effects and
impact on lifestyle fade, new issues emerge. As this EBP project demonstrated, TS/SCP
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and survivorship visits provide a similar impact at the end of treatment as chemotherapy
teaching provides at the start. Reduction in anxiety, fear, and confusion, increase in
knowledge, and improvement in self-care recommendations are all outcomes of
survivorship care supported in the literature.6,8,10–12
It is important to recognize aspects of this practice setting allowing the TS/SCP to
be constructed at a reduced time and cost, than reported in the literature.7,23 By creating a
standard template and populating more then 40% at the chemotherapy teaching session,
the NP was able to save considerable time then might have been appreciated in practices
where the TS/SCP is generated at the conclusion of treatment when the medical chart is
more extensive. The NPs at this practice were familiar with the patients, their treatment,
and problems they had encountered in the course of care. This proved advantageous, as
the NP was able to complete the TS/SCP in an efficient manner that might not be possible
in large practice or where the TS/SCP is produced in a dedicated survivorship clinic or by
a different set of providers. A meaningful reduction in the high labor costs reported by
other institutions was achieved by training the MAs to complete the data entry and
incorporating a significant portion of the process into the existing workflow.
While much of the literature on methods of delivering TS/SCP and survivorship
care has originated from academic and large oncology centers, the vast majority of cancer
patients receive the bulk of their treatment in community practices. For a large portion of
patients who receive treatment with curative intent, their life as a survivor will be far
longer then as an active cancer patient. It only makes sense, given this longevity,
attention be given to the needs of this population. As this project demonstrated, it is
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possible to not only to meet the requirements of the standards, but to provide value
added, cost-effective care, that is meaningful to both patients and other providers.
While the CSI tool measured the confidence the patient had in their knowledge, it
did not measure the accuracy of this knowledge. While not measured in a scientific
manner, during the review of the TS/SCP a number of participants discovered they had
an incorrect understanding of their diagnosis and/or treatment. This was most frequently
observed when reviewing the stage of cancer; patients often “up or down” staged their
disease. This was further validated, as the pre/post improvement in this domain was not
as robust as in the follow-up care domain. Kessels24 makes a salient point when stating
that during an encounter, patients immediately forget 40-80% of medical information and
50% of what is retained is erroneous. The more complex and/or distressing the
information, the more likely the patient will remember it inaccurately.24
Patient education reduces anxiety and depression, promotes self-care and
engagement, and has a positive effect on satisfaction, clinical outcomes, compliance, and
quality of life in the adult patients with cancer.25–27 Furthermore, the use of written
information improves the accuracy of recall of knowledge as well as demonstrating
improvement in adherence to recommendations.24–27 It is also cost-effective.28 Given the
length and complexity of cancer treatment the value of the TS/SCP and survivorship visit
becomes even more vital as it represents an opportunity to correct inaccurate and
erroneous information while educating on the next steps in care.
As demonstrated in this project, the advanced practice registered nurse (APRN) is
uniquely trained and positioned to provide survivorship care. Their role in symptom
management and support during the acute phase of cancer treatment results in frequent
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contact, allowing for understanding of the individual dynamics by which each patient and
their family experience cancer. The holistic lens by which APRNs view the care of
patients’ with serious illness, partnered with an education geared towards restoration of
health and wellness, provides an ideal skill set for the provision of survivorship care.
Conclusions
TS/SCPs only fulfill one of the ten recommendations in the area of survivorship
care outlined by the 2006 IOM report. As new drugs and treatments, whose long-term
side effects are still unknown, continue to expand the survivorship pool, the need to
implement comprehensive survivorship care within community-based settings is crucial.
The ability to provide curative cancer therapy is a noteworthy accomplishment worth
celebrating. However, it is not enough if patients are left debilitated, vulnerable to other
diseases, and with a poor quality of life. While transferring care to a dedicated
survivorship clinic or a PCP is a viable and proven model, the value of the IOM’s
direction “…This ‘Survivorship Care Plan’ should be written by the principle provider(s)
who coordinated oncology treatment…4” cannot be understated. It is these providers who
possess the knowledge to accurately set the course necessary to insure appropriate and
comprehensive follow-up.
The value of a TS/SCP is more pertinent then ever as our medical system remains
one of ever evolving and expanding complexity. Compliance with accreditation standards
and the IOM are the impetus for many organizations moving towards the provision of
TS/SCPs. Yet, empowering patients with knowledge to participate in their own
surveillance, risk reduction, and wellness, and improving the continuum of care, should
be the driving force for oncology providers in expanding the scope and practice of
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survivorship care. As the survivorship pool continues to grow, more research is needed to
comprehensively address the unique and changing needs of the 21st century cancer
patient.

Disclosures: The authors report no conflicts of interest in this work.
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Figure 1: Practice Model
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Figure 2: Confidence In Survivorship Information
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Figure 3: Participant and Provider Satisfaction
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Purpose: The purpose of this evidence-based practice (EBP) project was to incorporate a
treatment summary and survivorship care plan (TS/SCP) for women completing adjuvant
treatment for breast cancer in a community-based oncology practice.
Background: Over the last three decades, advances in screening, diagnosis, and
treatment have created an evolution in cancer care. In the United States it is estimated 12
to 14 million people are survivors of cancer. Breast cancer survivors are a prominent
subset, accounting for nearly 3.1 million survivors. The 2006 Institute of Medicine
report; From Cancer Patient to Cancer Survivors: Lost In Transition identified
survivorship as a distinct phase in the trajectory of cancer care and called attention to the
significant gaps in the provision and coordination of care to this population. TS/SCP’s are
a tool designed to improve outcomes, bridge the knowledge gap, decrease fragmentation
of care, and increase satisfaction in the post treatment phase of cancer care. TS/SCP’s are
incorporated into 43% of all National Cancer Institute (NCI) designated cancer centers.
In the project facility, dedicated survivorship care was absent and there was no TS/SCP
in use.
Practice Innovation Process: The John Hopkins Nursing Evidence-Based Practice
Model was used to guide this project. At the chemotherapy teaching visit, the Medical
Assistant documented the demographic information of the TS/SCP into the Journey
Forward Care Plan Builder. Using the pathology report, chemotherapy orders, and
oncology consultation, the NP developed the TS/SCP in preparation for a 50-minute
NP/patient survivorship visit. A copy of the NCI publication: Facing Forward: Life After
Cancer Treatment was reviewed and questions were addressed. Knowledge was
measured pre and post visit using the Confidence in Survivorship Information tool (CSI)
while satisfaction was measured using the Patient Satisfaction with Cancer Care (PSCC)
tool. A copy of the TS/SCP was provided to the patient and mailed to the treatment team
and PCP, whose satisfaction was surveyed. The project benchmark was for 80% of the
participants to increase their knowledge and satisfaction with breast cancer survivorship
care.
Outcomes: All of the 21 participants, or 100%, who participated in the practice
innovation had improvement in confidence in knowledge. Specifically, knowledge of
cancer diagnosis/treatment details improved from a mean average of 1.57 to 2.0 while
knowledge of prevention, late/long-term effects, resources, and family risk for cancer
increased from a mean average of 0.82 to 1.85. Similarly, satisfaction increased for 95%
of participants. Of the 73% of providers who completed the survey, 84% agreed/strongly
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agreed with the elements of the survey.
Conclusions: TS/SCP delivered in the context of a dedicated survivorship visit with an
NP consistently increases knowledge of all domains measured in the CSI tool.
Satisfaction with the intervention was positive. As with many education and wellness
interventions, the NP is uniquely qualified to support patients completing chemotherapy
with curative intent as they transition to survivorship care. Furthermore, depending on
payer mix, post treatment survivorship visits represent a potential revenue stream for a
community-based oncology practice.

27

30
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Background
• Of t he 1 4 .5 M Survivors, 3 .1 M are Breast
Cancer Survivors1 ,2
• Signif icant gaps ident if ied in knowledge,
provision, and coordinat ion of care3
• Survivors report
want ing more
inf ormat ion at t he end
of Tx4
• Survivors experience
residual physical/
psychosocial ef f ect s3 ,4 ,5
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Background
SURVIVORS• experience more chronic healt h
problems/ co-morbidit ies t hen
general populat ion 3 ,4
• report more t hen 2 5 problems,
concerns, and needs af t er Tx 3 ,5 ,6 ,7
• are at risk f or receiving inadequat e
healt hcare4 ,8
• f eel unprepared f or end of
t reat ment 4 ,6 ,7
• report high levels of st ress and
anxiet y 3 ,4 ,6 ,9

Evidence
• Treat ment summaries/ care plans are
f undament al t o nursing and medical
care
• Research shows signif icant impact wit h
t he use of int eract ive int ervent ions,
writ t en inf ormat ion, and
psychoeducat ion1 0 ,1 1
• Qualit at ive research support s t he use of
TS/ SCP4 ,5 ,6 ,7 ,8 ,1 2 -2 0
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Evidence
In From Cancer Pat ient t o Cancer
Survivor: Lost in Transit ion t he
IOM recommended TS/ SCP t o
bridge gaps in survivorship care3
In Delivering High-Qualit y Cancer

Care: Chart ing a New Course f or a
Syst em in Crisis, t he IOM
reit erat ed t he need f or TS/ SCP2 1

Benchmarks
• Only 4 3 % of NCI cancer cent ers
incorporat e TS/ SCPs f or breast and/ or
colorect al cancer survivors1 8 ,2 2
• The Commission on Cancer, ASCO Qualit y
Oncology Pract ice Init iat ive and t he
Nat ional Accredit at ion Program f or Breast
Cent ers all have st andards requiring TS/
SCP2 3 ,2 4 ,2 5
• Dedicat ion survivorship care was absent
at t he pract ice
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AIM:



Enhance knowledge and
increase sat isf act ion f or
women complet ing adjuvant
t reat ment f or breast cancer
 Single NP direct ed
survivorship visit
 Provision of a
personalized TS/ SCP



Disseminat e t his inf ormat ion t o
ot her providers involved in t he
care
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Evaluation
8 0 % of part icipant s
conf idence in
knowledge of
survivorship
inf ormat ion will
improve as measured
by pre/ post scores on

Conf idence in
Survivorship
Inf ormat ion Tool ( CSI)

NUMBER_________
PRE/POST

How confident are you about your knowledge of each of the
following aspects of your cancer and cancer related follow up care?
NOT AT ALL SOMEWHAT
VERY
CONFIDENT CONFIDENT CONFIDENT

The type of cancer you had?
The stage of cancer you have/had?
The treatments you received/are receiving for
cancer?
Things you can do to help prevent your cancer
from recurring?
The long-term physical effects you may
experience from cancer and its treatment?
Strategies for preventing long-term physical
effects of cancer treatment?
Strategies for treating long-term physical effects
of cancer treatment?
The long-term emotional effects you may
experience from cancer and its treatment?
Strategies for preventing long-term emotional
effects of cancer treatment?
Strategies for treating long-term emotional
effects of cancer treatment?
Community resources available to help you deal
with long-term effects of cancer and its
treatment?
Whether your family members are at increased
risk for cancer?
How your family members can get information
on their risk for cancer?

Evaluation
NUMBER_________

STRONGLY
AGREE

AGREE

CANNOT
DECIDE

DISAGREE

STRONGLY
DISAGREE

PLEASE RATE YOUR SATISFACTION WITH YOUR
SURVIVORSHIP VISIT TODAY.

1. I felt my health concerns were understood
2. I felt that I was treated with courtesy and respect
3. I felt included in decisions about my health
4. I was told how to take care of myself
5. I felt encouraged to talk about my personal health concerns
6. I felt I had enough time with my provider
7. My questions were answered to my satisfaction

8 0 % of part icipant s
overall sat isf act ion
will rat e at 4 or
bet t er on t he

8. Making an appointment was easy
9. I knew what the next step in my care would be
10. I felt confident in how I deal with the health care system
11. I was able to get advice I needed about my health issues
12. I knew who to contact when I had a question
13. I received all the services I needed
14. I am satisfied with the care I received
15. The providers seem to communicate well about my care
16. I received high quality care from my regular providers
17. I received high quality care from my specialist
18. My regular provider was informed about the results of the tests I
got.

ADDITIONAL COMMENTS_______________________________
________________________________________________________
________________________________________________________
________________________________________________________

Pat ient Sat isf act ion
wit h Cancer Care
( PSCC) Tool
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Evaluation

1. The TS/SCP is easy to understand.
2. The TS/SCP is concise and provides pertinent
information.
3. The TS/SCP will be a useful tool to promote
effective patient care
ADDITIONAL COMMENTS

________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________

• TS/ SCPs were creat ed using
t he Journey Forward Care Plan

Builder
• Women at t ended an NP led
survivorship visit

National Cancer Institute

Practice Innovation

• Pre-visit part icipant s
complet ed t he CSI t ool
• The TS/ SCP and NCI
publicat ion Facing Forward:
Lif e Af t er Cancer are reviewed
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STRONGLY
AGREE

AGREE

CANNOT
DECIDE

DISAGREE

TREATMENT SUMMARY AND SURVIVORSHIP CARE PLAN
(TS/SCP)

STRONGLY
DISAGREE

8 0 % of providers
will agree/ st rongly
agree t hat t he TS/
SCP was concise,
pert inent , and
usef ul

U.S.DEPARTMENT
OFHEALTHAND
HUMANSERVICES

National Institutes
of Health

Facing Forward
Life After Cancer Treatment

Practice Innovation
• Post -visit , part icipant s complet ed t he
CSI Tool and PSCC Tool
• TS/ SCP was scanned int o t he EMR,
survivorship visit not e was creat ed, and
ref errals complet ed
• TS/ SCP was mailed t o t he PCP, ot her
providers.

Results
• 2 1 women
part icipat ed, 1 0 0 %
experienced
improvement
• Mean conf idence in
knowledge Dx/ Tx
det ails 1 .5 7 t o 2 .0
• Mean conf idence in
knowledge prevent ion,
lat e/ long-t erm ef f ect s,
resources, f amiliar risk
 .8 2 t o 1 .8 5
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CONFIDENCE IN
SURVIVORSHIP
INFORMATION
2
1.8
1.6
1.4
1.2
1

PRE-VISIT

0.8

POST-VISIT

0.6
0.4
0.2
0
AVG Q1-Q3

AVG Q4-Q13

Results
• 2 6 providers were
mailed surveys,1 9 were
ret urned ( 7 3 %)
• 8 4 % of providers
agreed/ st rongly agreed
wit h all element s of t he
survey
• 9 5 % of t he women
rat ed sat isf act ion at 4
or bet t er

95%
84%
73%

Precent of
Providers
Returning
Survey

Percent of
Provider Agree/
Stongly Agree

Percent Patient
Rating
Satisfaction
Agree/Strongly
Agree

Economics
• Average reimbursement f or
payer mix level 5 f ollow-up
visit
• Subt ract ed est imat es of
t ime/ cost f or NP and MA
based on hourly rat es
• Addit ional $ 5 .0 0 t o cover
cost s of NCI booklet
• Each visit generat ed $ 2 5 -$ 3 0
of revenue
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• CSI t ool only capt ured what t he PTs
conf idence was, not if t he knowledge was
accurat e
• Unique aspect s of t he pract ice set t ing
allowing f or signif icant reduct ion in t ime/
cost s
• Cost s est imat ions were simplist ic and
act ual revenue maybe more or less

Practice Implications
T S/ SCP
SCP and Sur
Su r v iv ors
or ship v isit s:
• Improve knowledge and ease t ransit ion
• Provide opport unit y f or NP t o educat e:
healt hy behaviors, risk reduct ion, assess
impact of t reat ment
• Engages PT in surveillance,
risk reduct ion, wellness
• Serves as a road map
clearly def ining EBP
guidelines f or f ollow-up
care t o ent ire t eam
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Conclusions
• TS/ SCP provide similar impact
at t he end of TX as chemo
t eaching does at t he beginning
• Pat ient s need/ benef it f rom
assessment , educat ion and
goal set t ing at t his junct ure
• TS/ SCP should be complet ed
by t he principle providers
• Survivorship care is pot ent ially
revenue generat ing and can
decrease healt hcare cost s

Next Steps
• Addit ion of adjuvant Colon Cancer by
Summer 2 0 1 5
• Explore int egrat ed EMR syst ems: OnQ,
Varian Equicare CS
• Development of t imeline f or addit ion of all
diagnoses in which adjuvant t reat ment is
employed: Lymphoma, Lung, Prost at e…
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